News
AcelRx Pharmaceuticals has begun the final phase of its three studies on a new patient-controlled analgesia system, ARX-01, the Sufentanil NanoTab PCA System, according to PharmaBiz.com.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback